Literature DB >> 26046059

The prognostic value of HPV in head and neck cancer patients undergoing postoperative chemoradiotherapy.

Randall J Kimple1, Paul M Harari1.   

Abstract

Entities:  

Year:  2015        PMID： 26046059      PMCID： PMC4437932          DOI： 10.3978/j.issn.2305-5839.2015.01.37

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  18 in total

1.  Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer.

Authors:  Daniel W Vermeer; William C Spanos; Paola D Vermeer; Annie M Bruns; Kimberly M Lee; John H Lee
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

2.  HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Authors:  Fabian Lohaus; Annett Linge; Inge Tinhofer; Volker Budach; Eleni Gkika; Martin Stuschke; Panagiotis Balermpas; Claus Rödel; Melanie Avlar; Anca-Ligia Grosu; Amir Abdollahi; Jürgen Debus; Christine Bayer; Claus Belka; Steffi Pigorsch; Stephanie E Combs; David Mönnich; Daniel Zips; Cläre von Neubeck; Gustavo B Baretton; Steffen Löck; Howard D Thames; Mechthild Krause; Michael Baumann
Journal:  Radiother Oncol       Date:  2014-12-02       Impact factor: 6.280

3.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

4.  HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity.

Authors:  Thorsten Rieckmann; Silke Tribius; Tobias J Grob; Felix Meyer; Chia-Jung Busch; Cordula Petersen; Ekkehard Dikomey; Malte Kriegs
Journal:  Radiother Oncol       Date:  2013-04-17       Impact factor: 6.280

5.  Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage.

Authors:  Jung Wook Park; Kwangok P Nickel; Alexandra D Torres; Denis Lee; Paul F Lambert; Randall J Kimple
Journal:  Radiother Oncol       Date:  2014-09-09       Impact factor: 6.280

6.  Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.

Authors:  Paul M Harari; Jonathan Harris; Merrill S Kies; Jeffrey N Myers; Richard C Jordan; Maura L Gillison; Robert L Foote; Mitchell Machtay; Marvin Rotman; Deepak Khuntia; William Straube; Qiang Zhang; Kian Ang
Journal:  J Clin Oncol       Date:  2014-07-07       Impact factor: 44.544

7.  Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trials.

Authors:  Pernille Lassen; Jens Overgaard; Jesper Grau Eriksen
Journal:  Radiother Oncol       Date:  2013-09-20       Impact factor: 6.280

8.  Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.

Authors:  William C Spanos; Paul Nowicki; Dong Wook Lee; Andrew Hoover; Bruce Hostager; Anjali Gupta; Mary E Anderson; John H Lee
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-11

Review 9.  Is radiation dose reduction the right answer for HPV-positive head and neck cancer?

Authors:  Randall J Kimple; Paul M Harari
Journal:  Oral Oncol       Date:  2013-10-14       Impact factor: 5.337

10.  Prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in the United States across time.

Authors:  Andrew P Stein; Sandeep Saha; Menggang Yu; Randall J Kimple; Paul F Lambert
Journal:  Chem Res Toxicol       Date:  2014-04-02       Impact factor: 3.739
View more
  6 in total

1.  HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC.

Authors:  Fabian Lohaus; Annett Linge; Michael Baumann
Journal:  Ann Transl Med       Date:  2015-10

2.  Rapid Nanophotonics Assay for Head and Neck Cancer Diagnosis.

Authors:  P Vohra; P Strobbia; H T Ngo; W T Lee; T Vo-Dinh
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379

Review 3.  The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications.

Authors:  Steven F Powell; Lexi Vu; William C Spanos; Dohun Pyeon
Journal:  Cancers (Basel)       Date:  2021-10-17       Impact factor: 6.575

4.  The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma.

Authors:  Imogen Sharkey Ochoa; Esther O'Regan; Mary Toner; Elaine Kay; Peter Faul; Connor O'Keane; Roisin O'Connor; Dorinda Mullen; Mataz Nur; Eamon O'Murchu; Jacqui Barry-O'Crowley; Niamh Kernan; Prerna Tewari; Helen Keegan; Sharon O'Toole; Robbie Woods; Susan Kennedy; Kenneth Feeley; Linda Sharp; Tarik Gheit; Massimo Tommasino; John J O'Leary; Cara M Martin
Journal:  Cancers (Basel)       Date:  2022-09-03       Impact factor: 6.575

5.  Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.

Authors:  Jacqueline Nathansen; Vasyl Lukiyanchuk; Linda Hein; Maya-Isabel Stolte; Kerstin Borgmann; Steffen Löck; Ina Kurth; Michael Baumann; Mechthild Krause; Annett Linge; Anna Dubrovska
Journal:  Oncogene       Date:  2021-06-02       Impact factor: 9.867

Review 6.  Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications.

Authors:  Claudia Peitzsch; Jacqueline Nathansen; Sebastian I Schniewind; Franziska Schwarz; Anna Dubrovska
Journal:  Cancers (Basel)       Date:  2019-05-02       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.